Next, mechanistically, PR and these bioactive ingredients provided relief from acute inflammatory injuries mainly by inhibiting ER stress-mediated NLRP3 inflammasome, which could be a novel therapeutic target for ALI. Here, NLRP3 is linked to acute respiratory distress syndrome.